Printer Friendly
The Free Library
14,598,536 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Duchenne Muscular Dystrophy Foundations Work Together to Fund Novel Therapy for Leading Genetic Killer of Young Boys.


DENVER -- Four Duchenne foundations, Charley's Fund, CureDuchenne, The Nash Avery Foundation and a private family foundation, are working together to aggressively fund research that could help extend the lives of thousands of boys worldwide afflicted af·flict  
tr.v. af·flict·ed, af·flict·ing, af·flicts
To inflict grievous physical or mental suffering on.



[Middle English afflighten, from afflight,
 with Duchenne Muscular Dystrophy Duchenne muscular dystrophy (DMD)
The most severe form of muscular dystrophy, DMD usually affects young boys and causes progressive muscle weakness, usually beginning in the legs.
 (DMD (1) (Digital Micromirror Device) See DLP.

(2) (Digital Multi-layer Disk) See high-def DVD formats.
). They have pooled their resources to fund a novel approach for a potential treatment being conducted by Dr. Brian Tseng, MD/PhD, a prominent muscular dystrophy muscular dystrophy (dĭs`trōfē), any of several inherited diseases characterized by progressive wasting of the skeletal muscles. There are five main forms of the disease.  researcher at the University of Colorado Health Sciences Center The University of Colorado Health Sciences Center (UCHSC) is part of the University of Colorado System. It has recently been merged with the University of Colorado at Denver (UCD) to form the University of Colorado at Denver and Health Sciences Center.  and a doctor at The Children's Hospital A children's hospital is a hospital which offers its services exclusively to children. The number of children's hospitals proliferated in the 20th century, as pediatric medical and surgical specialties separated from internal medicine and adult surgical specialties.  of Denver. Dr. Tseng's lab is testing the effect of a membrane sealant on the leaky dystrophin-deficient membranes of skeletal muscle cells. The purpose of this project is to develop an effective treatment that will strengthen the cell membranes, using a chemical called poloxamer 407, as a chemical Band-Aid, patching these holes and tears in the muscle.

"We are currently testing a compound called poloxamer 407 as a 'molecular band-aid' to patch muscle membrane leaks and evaluate if it can improve skeletal muscle integrity and function," said Dr. Tseng. "This direction was triggered by two high school students working in my lab, Lalith Polepeddi and Mike Polmear (Denver's own Whiz Kids “Whiz Kids” redirects here. For other uses, see Whiz Kids (disambiguation).
The Whiz Kids were ten United States Army Air Forces veterans of World War II who became Ford Motor Company executives in 1946.

They were led by their commanding officer, Charles B.
). The original idea of using a smaller membrane sealant compound called poloxamer 188 for cardiac muscle cardiac muscle
n.
The muscle of the heart, consisting of anastomosing transversely striated muscle fibers formed of cells united at intercalated disks; the myocardium. Also called muscle of heart.
 was developed in Dr. Joseph Metzger's lab at the University of Michigan (body, education) University of Michigan - A large cosmopolitan university in the Midwest USA. Over 50000 students are enrolled at the University of Michigan's three campuses. The students come from 50 states and over 100 foreign countries. . Poloxamer 407 is thought to be a relatively safe compound. In fact, poloxamer 407 is found in daily household commodities such as mouthwashes, children's cavity rinses, suppositories suppositories,
n.pl solid capsules made of materials that melt at body temperature and are used to deliver medicinal substances into the rectum.
 and also used as the solid coating of many pharmaceutical pills and tablets. This study is significant because it could one day represent a therapeutic treatment designed to compliment and enhance other therapies for DMD. In essence, we are trying to help seal up the muscles' leaky membranes. This is not a cure and the research is very preliminary, but it is a direction that has not been explored before."

"We're not parent support organizations. Our foundations are focused on the business of finding and funding promising research and technologies that could help save our sons," said Debra Miller, President, CureDuchenne. "We're pooling our resources to maximize our effectiveness. We work with prominent scientists around the world, do substantial due diligence Research; analysis; your homework. This term has caught on in all industries, because it sounds so "wired." Who would want to do analysis or research when they can do due diligence. See wired.  on new projects and work together to quickly fund those that have high potential to impact the lives of our Duchenne boys. We are passionate about our success, as each of us has a personal interest in making sure we make our deadline C* our sons."

About Duchenne Muscular Dystrophy (DMD)

Every year, an estimated 20,000 babies (almost all of them boys) are born with Duchenne Muscular Dystrophy, worldwide. Their muscle cells will die and not regenerate. They will be in wheel chairs by 12 and, historically, most have not survived their teenage years. An estimated 1 in every 3,500 boys is affected by DMD. It knows no boundaries and crosses all cultures and races. There currently is no cure, but for the first time there are promising therapies on the horizon.

About the Duchenne Foundations

Charley's Fund is a non-profit organization A non-profit organization (abbreviated "NPO", also "non-profit" or "not-for-profit") is a legally constituted organization whose primary objective is to support or to actively engage in activities of public or private interest without any commercial or monetary profit purposes.  founded by Tracy and Benjamin Seckler. We direct money into the hands of researchers who have the best shot at developing a treatment or cure for Duchenne Muscular Dystrophy. Our goal is to cure DMD in time to save Charley's life and the lives of thousands of boys like him. For more information contact: Charley's Fund, PO Box 297, South Egremont, MA 01258. Visit our website at www.charleysfund.org. Call (413) 528-5744 or (877) 436-3363 (877-4-END-DMD) or email info@charleysfund.org.

CureDuchenne is a non-profit organization founded in 2003 by Debra and Paul Miller The name Paul Miller is shared by a number of people.
  • Paul Miller (North Carolina politician), the Democratic member of the North Carolina General Assembly
  • Paul Miller (Canadian politician), the Ontario New Democratic Party MPP for the constituency of Hamilton
. Our vision is our name C* to cure Duchenne Muscular Dystrophy. CureDuchenne aggressively seeks out and funds research and expedites practical therapies that will help save THIS generation of Duchenne boys. For more information, contact: CureDuchenne, 3334 E. Coast Hwy. #157, Corona del Mar, CA 92625. Visit our website at www.cureduchenne.org. Call (949) 721-4063 or email debra@cureduchenne.org.

The Nash Avery Foundation is a non-profit organization founded by Tom and Angie Wicka. Our Mission is to defeat Duchenne Muscular Dystrophy, so that one day soon these boys will live happy lives well beyond their twentieth birthdays. We will relentlessly push, prod and pound on any door in order to make people aware of the deadliness of DMD and to raise funds to cure these children. For more information, contact: The Nash Avery Foundation, 3109 West 50th Street, Suite 205, Minneapolis, MN 55410-2102. Call (952) 470-6490 or email bashfornash@iwco.com.

For more information on Dr. Brian Tseng and the Denver "Whiz Kids," contact: TsengLab at www.uchsc.edu/sm/neuro/dmd/intro.htm or contact Brian Tseng, MD/PhD, at brian.tseng@uchsc.edu. View ABC's interview, High School Whiz Kids Search for MD Cure, at abcnews.go.com/GMA/Health/story?id=1808757.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 8, 2006
Words:815
Previous Article:Casio Expands Line of DivX Certified Digital Cameras.
Next Article:Dell Launches Removable Hard Drive to Ease Backup Pain.
Topics:



Related Articles
Muscular dystrophy defect located.
Muscular dystrophy gene cornered.
Steroid slackens pace of muscular dystrophy. (prednisone and Duchenne's muscular dystrophy)
Gene fix for muscular dystrophy defect. (gene-transfer therapy)
Muscular dystrophy: new focus on myoblasts. (cell therapy treatment)
Our future genes. (genetic research)
New tools for muscular dystrophy research. (new cell transplantation approach and new mouse model)(Brief Article)
Nutrition for boys with Duchenne muscular dystrophy. (Review).
The challenge of gene therapy.(Opinion)(Brief Article)
The muscular dystrophies: from genes to therapies.(Perspective)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles